Which closed-end funds own Palvella Therapeutics Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $24.1M. Security type: common equity. Country: United States. CUSIP 697947109 · ISIN US6979471090 · ticker PVLA.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.90% | $6.2M | 40,805 sh | $690M | 3.4% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.89% | $12.1M | 79,433 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.30% | $3.2M | 21,246 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.12% | $685K | 4,480 sh | $573M | 2.8% discount | Jun 30, 2026 |
| RVT Royce Small-Cap Trust | U.S. Equity | 0.07% | $1.8M | 12,000 sh | $2.6B | 13.5% discount | Jun 30, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “PVLA” → · Compare two funds’ portfolios →